<p>Cero Therapeutics Holdings Inc. held a special meeting of stockholders on December 19, 2025. Stockholders approved an amendment to the company’s certificate of incorporation to authorize a reverse stock split at a ratio to be determined by the Board of Directors within a specified range. An amendment to the 2024 Equity Incentive Plan to increase the number of shares available for issuance was also approved. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cero Therapeutics Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-123912), on December 19, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

CERO

<p>Cero Therapeutics Holdings Inc. held a special shareholder meeting on December 19, 2025, where stockholders approved amendments to authorize a reverse stock split and increase shares in the 2024 Equity Incentive Plan.</p>

Cero Therapeutics Holdings Inc. held special shareholder meeting